Authors/Disclosures
|
Syndi Seinfeld, DO, FAAN
(Joe DiMaggio Children's Hospital)
|
No disclosure on file |
|
John M. Pellock, MD
(Virginia Commonwealth University)
|
No disclosure on file |
|
Shlomo Shinnar, MD, PhD
(Montefiore Medical Center)
|
No disclosure on file |
|
Dale C. Hesdorffer
(Columbia University)
|
No disclosure on file |
|
Katherine D. Mathews, MD, FAAN
(University of Iowa - Dept of Pediatrics)
|
Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen. |
|
|
No disclosure on file |
|
Kathryn O'Hara
|
No disclosure on file |
|
Michael Levy, MD, PhD, FAAN
(Massachusetts General Hospital/Harvard Medical School)
|
Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health. |
|
Douglas R. Nordli, Jr., MD
(University of Chicago)
|
Dr. Nordli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Nordli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. |
|
L M. Frank, MD
(Children's Specialty Group)
|
Dr. Frank has received stock or an ownership interest from ReAlta Life Sciences. |
|
William Gallentine, DO
(Stanford University Medical Center)
|
No disclosure on file |
|
Solomon L. Moshe, MD, FAAN
|
Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Moshe has received publishing royalties from a publication relating to health care. Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of study sections with NINDS. |
|
|
No disclosure on file |
|
|
No disclosure on file |